Redian新闻
>
Small Oncology stock -- CYTR
avatar
Small Oncology stock -- CYTR# Stock
g*e
1
Have been Searched promising oncology stock for a couple of day. I think
CYTR is a very good candidate:
Reasons for buy:
1. Cash rich $44 min comparing to this burn rate and market size.
2. Promising pipeline:
Three compounds: Aldoxorubicin, Tamibarotene and Bafetinib have been
advanced to Phase II. Four study results due on next year.
3. Insider buying:
Oct 21, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more)
115,000 Direct Purchase at $2.51 per share.
Oct 18, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more) 65
,000 Direct Purchase at $2.51 per share.
Oct 17, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more) 1,
200,000 Direct Purchase at $2.50 per share.
Just for your reference, please DD before investing.
Good luck!!
avatar
k*4
2
too many letters, hard to remember

【在 g****e 的大作中提到】
: Have been Searched promising oncology stock for a couple of day. I think
: CYTR is a very good candidate:
: Reasons for buy:
: 1. Cash rich $44 min comparing to this burn rate and market size.
: 2. Promising pipeline:
: Three compounds: Aldoxorubicin, Tamibarotene and Bafetinib have been
: advanced to Phase II. Four study results due on next year.
: 3. Insider buying:
: Oct 21, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more)
: 115,000 Direct Purchase at $2.51 per share.

相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。